<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket20117219-27</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-4358</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Популяция антитиреоидных аутоантител как источник антител различных уровней специфичности и функциональности: клиническая значимость феномена комбинаторики при мониторинге пациентов с аутоиммунными заболеваниями щитовидной железы</article-title><trans-title-group xml:lang="en"><trans-title>Population of antithyroid autoantibodies as a source of antibodies of various levels of specificity and functionality: the clinical importance of a phenomenon of combination theory at monitoring of patients with autoimmune diseases of a thyroid gland</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Andreeva</surname><given-names>A V</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-эндокринолог, ассистент кафедры эндокринологии и диабетологии ГОУ ВПО МГМСУ Росздрава</p></bio><email xlink:type="simple">_1410_@rambler.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Suchkova</surname><given-names>E N</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, доцент кафедры терапии с курсом эндокринологии Астраханской медицинской академии им. А.В. Луначарского</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Gadjieva</surname><given-names>S I</given-names></name></name-alternatives><bio xml:lang="ru"><p>ординатор ГОУ ВПО Первого МГМУ им. И.М.Сеченова</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Mkrtumyan</surname><given-names>A M</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, профессор, заведующий кафедрой эндокринологии и диабетологии ГОУ ВПО МГМСУ Росздрава</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Grishina</surname><given-names>T I</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, профессор, заведующая кафедрой клинической иммунологии ГОУ ВПО МГМСУ Росздрава</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Suchkov</surname><given-names>S V</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор мед. наук, профессор кафедры клинической иммунологии лечебного факультета ГОУ ВПО МГМСУ Росздрава, профессор кафедры общей патологии ГОУ ВПО Первого МГМУ им. И.М. Сеченова</p></bio><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Notkins</surname><given-names>A L</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор наук, профессор, заведующий отделом экспериментальной медицины и иммунологии Национального института здоровья, Бетезда, Мэриленд, США</p></bio><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>15</day><month>06</month><year>2011</year></pub-date><volume>7</volume><issue>2</issue><issue-title>ТОМ 7, №2 (2011)</issue-title><fpage>19</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Andreeva A.V., Suchkova E.N., Gadjieva S.I., Mkrtumyan A.M., Grishina T.I., Suchkov S.V., Notkins A.L., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Andreeva A.V., Suchkova E.N., Gadjieva S.I., Mkrtumyan A.M., Grishina T.I., Suchkov S.V., Notkins A.L.</copyright-holder><copyright-holder xml:lang="en">Andreeva A.V., Suchkova E.N., Gadjieva S.I., Mkrtumyan A.M., Grishina T.I., Suchkov S.V., Notkins A.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/4358">https://www.cet-endojournals.ru/jour/article/view/4358</self-uri><abstract><p>В обзоре литературы обсуждается роль и клинико-патологическая значимость антитиреоидных аутоантител (аутоАТ), различающихся по специфичности , а именно АТ к тиреоглобулину (АТ-ТГ) и АТ к тиреоидной пероксидазе (АТ-ТПО), анти-TGPO, и функциональности , а именно АТ-протеаз, в патогенезе аутоиммунных заболеваний щитовидной железы (ЩЖ) и возможности их использования в современной диагностике аутоиммунных заболеваний ЩЖ.</p></abstract><trans-abstract xml:lang="en"><p>The review of literature is dedicated to comparative analysis of pathogenetic and clinicodiagnostic significance of antithyroid autoantibodies (autoAB) differing in their specificity (АB to thyroglobulin (anti-TG) and АB to thyroid peroxidase (anti-TPO), anti-TGPO), and functionality TG- and TPO-antibodies, namely antibodies-proteases in pathogenesis autoimmune diseases thyroid gland and possibility of their use in modern diagnostics of autoimmune thyroid diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>антитиреоидные аутоантитела (аутоАТ)</kwd><kwd>антитела-протеазы</kwd><kwd>функциональность аутоАТ</kwd><kwd>АТ-ТГ аутоАТ</kwd><kwd>АТ-ТПО аутоАТ</kwd><kwd>анти-TGPO</kwd></kwd-group><kwd-group xml:lang="en"><kwd>antithyroid auto-AB</kwd><kwd>AB-proteases</kwd><kwd>AB-functionality</kwd><kwd>anti-TG auto-AB</kwd><kwd>anti-TPO auto-AB</kwd><kwd>anti-TGPO auto-AB</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьев И.И., Пономаренко Н.А., Решетняк А.В. и др. Каталитические антитела в медицине: Специфическая деградация аутоантигенов и новые подходы к инактивации патогенов // Мол. мед. 2004. №3. С. 48–55.</mixed-citation><mixed-citation xml:lang="en">Воробьев И.И., Пономаренко Н.А., Решетняк А.В. и др. Каталитические антитела в медицине: Специфическая деградация аутоантигенов и новые подходы к инактивации патогенов // Мол. мед. 2004. №3. С. 48–55.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов И.И., Трошина Е.А, Антонова С.С. и др. Аутоиммунные заболевания щитовидной железы: состояние проблемы // Пробл. эндокринол. 2002. Т. 48. №2. С. 6–13.</mixed-citation><mixed-citation xml:lang="en">Дедов И.И., Трошина Е.А, Антонова С.С. и др. Аутоиммунные заболевания щитовидной железы: состояние проблемы // Пробл. эндокринол. 2002. Т. 48. №2. С. 6–13.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Иванова Е.В., Богатырева З.И., Исаева М.А. и др. Антитиреоидные антитела различных уровней специфичности в патогенезе и диагностике аутоиммунных заболеваний щитовидной железы // Тер. арх. 2009. №10. С. 54–56.</mixed-citation><mixed-citation xml:lang="en">Иванова Е.В., Богатырева З.И., Исаева М.А. и др. Антитиреоидные антитела различных уровней специфичности в патогенезе и диагностике аутоиммунных заболеваний щитовидной железы // Тер. арх. 2009. №10. С. 54–56.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Исаева М.А., Богатырева З.И., Андреева А.И. др. Антителапротеазы при аутоиммунных заболеваниях щитовидной железы: патогенетические и клинические аспекты // Врач. 2009. №7. С. 87–100.</mixed-citation><mixed-citation xml:lang="en">Исаева М.А., Богатырева З.И., Андреева А.И. др. Антителапротеазы при аутоиммунных заболеваниях щитовидной железы: патогенетические и клинические аспекты // Врач. 2009. №7. С. 87–100.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Мисиков В.К., Кимова М.В., Дурова О.М. и др. Каталитические аутоантитела при рассеянном склерозе // Бюл. экспер. биол. 2005. №1. С. 98–101.</mixed-citation><mixed-citation xml:lang="en">Мисиков В.К., Кимова М.В., Дурова О.М. и др. Каталитические аутоантитела при рассеянном склерозе // Бюл. экспер. биол. 2005. №1. С. 98–101.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко Н.А., Дурова О.М., Воробьев И.И. и др. К вопросу о каталитической активности аутоантител при рассеянном склерозе // Докл. АН (биохимия, биофизика, молекулярная биология). 2004. Т. 395. №6. С. 839–842.</mixed-citation><mixed-citation xml:lang="en">Пономаренко Н.А., Дурова О.М., Воробьев И.И. и др. К вопросу о каталитической активности аутоантител при рассеянном склерозе // Докл. АН (биохимия, биофизика, молекулярная биология). 2004. Т. 395. №6. С. 839–842.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Шилин Д.Е. Исследование антитиреоидных антител и тироглобулина в диагностике и контроле терапии заболеваний щитовидной железы // Лаборатория. 1998. №11. С. 3–6.</mixed-citation><mixed-citation xml:lang="en">Шилин Д.Е. Исследование антитиреоидных антител и тироглобулина в диагностике и контроле терапии заболеваний щитовидной железы // Лаборатория. 1998. №11. С. 3–6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Amino N., Kubota S., Morita S. et al. Quantitative Measurement of Anti-TSH Receptor Antibodies is Useful for the Evaluation of Treatment Effect // Thyroid. 2007. V. 17(1). P. 85–86.</mixed-citation><mixed-citation xml:lang="en">Amino N., Kubota S., Morita S. et al. Quantitative Measurement of Anti-TSH Receptor Antibodies is Useful for the Evaluation of Treatment Effect // Thyroid. 2007. V. 17(1). P. 85–86.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bogner U., Kotulla P., Peters H. et al. Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis // Acta Endocr. 1990. V. 123(4). P. 431–437.</mixed-citation><mixed-citation xml:lang="en">Bogner U., Kotulla P., Peters H. et al. Thyroid peroxidase/microsomal antibodies are not identical with thyroid cytotoxic antibodies in autoimmune thyroiditis // Acta Endocr. 1990. V. 123(4). P. 431–437.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bulow Pedersen I., Laurberg P., Knudsen N. et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure // Clin. Endocr. 2005. V. 62(6). P. 713–720.</mixed-citation><mixed-citation xml:lang="en">Bulow Pedersen I., Laurberg P., Knudsen N. et al. A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure // Clin. Endocr. 2005. V. 62(6). P. 713–720.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Сhardes T., Chapal N., Bresson D. et al. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases // Immunogenetics. 2002. V. 54(3). P. 141–157.</mixed-citation><mixed-citation xml:lang="en">Сhardes T., Chapal N., Bresson D. et al. The human anti-thyroid peroxidase autoantibody repertoire in Graves' and Hashimoto's autoimmune thyroid diseases // Immunogenetics. 2002. V. 54(3). P. 141–157.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chiovato L., Latrofa F., Braverman L.E. et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens // Ann. Intern. Med. 2003. V. 2. 139(5 Pt 1). P. 346–351.</mixed-citation><mixed-citation xml:lang="en">Chiovato L., Latrofa F., Braverman L.E. et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens // Ann. Intern. Med. 2003. V. 2. 139(5 Pt 1). P. 346–351.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Demers L.M., Spencer C.A. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease // Clin. Endocr. 2003. V. 58(2). P. 138–140.</mixed-citation><mixed-citation xml:lang="en">Demers L.M., Spencer C.A. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease // Clin. Endocr. 2003. V. 58(2). P. 138–140.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Demirbilek H., Kandemir N., Gonc E.N. et al. Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease // J. Pediatr. Endocr. Met. 2007. V. 20(11). P. 1199–205.</mixed-citation><mixed-citation xml:lang="en">Demirbilek H., Kandemir N., Gonc E.N. et al. Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease // J. Pediatr. Endocr. Met. 2007. V. 20(11). P. 1199–205.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Estienne V., Duthoit C., Costanzo V.D. et al. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters // Eur. J. Endocrinol. 1999. V. 141(6). P. 563–569.</mixed-citation><mixed-citation xml:lang="en">Estienne V., Duthoit C., Costanzo V.D. et al. Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters // Eur. J. Endocrinol. 1999. V. 141(6). P. 563–569.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Giovanella L., Ceriani L., Ghelfo A. et al. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism // Horm. Met. Res. 2008. V. 40(7). P. 484–486.</mixed-citation><mixed-citation xml:lang="en">Giovanella L., Ceriani L., Ghelfo A. et al. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism // Horm. Met. Res. 2008. V. 40(7). P. 484–486.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gleicher N., Barad D., Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? // Autoimmun. Rev. 2007. V. 7(1). P. 42–45.</mixed-citation><mixed-citation xml:lang="en">Gleicher N., Barad D., Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? // Autoimmun. Rev. 2007. V. 7(1). P. 42–45.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Tada H., Mizuta I., Takano T. et al. Blocking-type anti-TSH receptor antibodies and relathion to responsiveness to antithyroid drug therapy and remission in Graves' disease // Clin. Endocr. 2003. V. 58(4). P. 403–408.</mixed-citation><mixed-citation xml:lang="en">Tada H., Mizuta I., Takano T. et al. Blocking-type anti-TSH receptor antibodies and relathion to responsiveness to antithyroid drug therapy and remission in Graves' disease // Clin. Endocr. 2003. V. 58(4). P. 403–408.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jasani B., Ternynck T., Lazarus J.H. et al. Natural antibody status in patients with Hashimoto's thyroiditis // J. Clin. Lab. Immunol. 1999. V. 51(1). P. 9–12.</mixed-citation><mixed-citation xml:lang="en">Jasani B., Ternynck T., Lazarus J.H. et al. Natural antibody status in patients with Hashimoto's thyroiditis // J. Clin. Lab. Immunol. 1999. V. 51(1). P. 9–12.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kotani T. Anti-TPO autoantibodies // Rinsho Byori. 1998. V. 46(4). P. 324–330.</mixed-citation><mixed-citation xml:lang="en">Kotani T. Anti-TPO autoantibodies // Rinsho Byori. 1998. V. 46(4). P. 324–330.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Кratzch J., Fiedler G.M., Leichtle A. at al. New reference intervals for hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid // Clin. Chem. 2005. V. 51(8). P. 1480–1486.</mixed-citation><mixed-citation xml:lang="en">Кratzch J., Fiedler G.M., Leichtle A. at al. New reference intervals for hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid // Clin. Chem. 2005. V. 51(8). P. 1480–1486.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kuwabara A, Kobayashi I. Microsomal antibody // Nippon Rinsho. 1999. V. 57(8). P. 1815–1818.</mixed-citation><mixed-citation xml:lang="en">Kuwabara A, Kobayashi I. Microsomal antibody // Nippon Rinsho. 1999. V. 57(8). P. 1815–1818.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Lacroix-Desmazes S., Wootla B., Delignat S. et al. Pathophysiology of catalytic antibodies // Immunol. Lett. 2006. V. 103(1). P. 3–7.</mixed-citation><mixed-citation xml:lang="en">Lacroix-Desmazes S., Wootla B., Delignat S. et al. Pathophysiology of catalytic antibodies // Immunol. Lett. 2006. V. 103(1). P. 3–7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lui C., Hermsen D., Domberg J. et al. Comparison of M22-based ELISA and human-TSH-receptor based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases // Horm. Met. Res. 2008. P. 479–483.</mixed-citation><mixed-citation xml:lang="en">Lui C., Hermsen D., Domberg J. et al. Comparison of M22-based ELISA and human-TSH-receptor based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases // Horm. Met. Res. 2008. P. 479–483.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Mancini G., Carbonara A.O., Heremans J.F. Immunochemical quantitation of antigens by single radial immunodiffusion // Immunochemistry. 1965. V. 2(3). P. 235–254.</mixed-citation><mixed-citation xml:lang="en">Mancini G., Carbonara A.O., Heremans J.F. Immunochemical quantitation of antigens by single radial immunodiffusion // Immunochemistry. 1965. V. 2(3). P. 235–254.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mann K., Janssen O.E. Subclinical hypothyroidism - what level of TSH is an indication for substitution? // MMW Fortschr. Med. 2006. V. 2. 148(9). P. 26–29.</mixed-citation><mixed-citation xml:lang="en">Mann K., Janssen O.E. Subclinical hypothyroidism - what level of TSH is an indication for substitution? // MMW Fortschr. Med. 2006. V. 2. 148(9). P. 26–29.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mariotti S., Barbesino G., Caturegli P. et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? // J. Clin. Endocr. Met. 1995. V. 80(2). P. 468–472.</mixed-citation><mixed-citation xml:lang="en">Mariotti S., Barbesino G., Caturegli P. et al. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? // J. Clin. Endocr. Met. 1995. V. 80(2). P. 468–472.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">McIntosh R.S., Tandon N., Metcalfe R.A. et al. Cloning and analysis of IgM anti-thyroglobulin autoantibodies from patients with Hashimoto's thyroiditis // Biochim. Biophys. Acta. 1994. V. 29. 1227(3). P. 171–176.</mixed-citation><mixed-citation xml:lang="en">McIntosh R.S., Tandon N., Metcalfe R.A. et al. Cloning and analysis of IgM anti-thyroglobulin autoantibodies from patients with Hashimoto's thyroiditis // Biochim. Biophys. Acta. 1994. V. 29. 1227(3). P. 171–176.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Moore D.C. Natural course of 'subclinical' hypothyroidism in childhood and adolescence // Arch. Pediatr. Adolesc. Med. 1996. V. 150(3). P. 293–297.</mixed-citation><mixed-citation xml:lang="en">Moore D.C. Natural course of 'subclinical' hypothyroidism in childhood and adolescence // Arch. Pediatr. Adolesc. Med. 1996. V. 150(3). P. 293–297.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Morita T., Tamai H., Oshima A. et al. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis // J. Clin. Endocr. Met. 1990. V. 71(4). P. 1051–1055.</mixed-citation><mixed-citation xml:lang="en">Morita T., Tamai H., Oshima A. et al. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis // J. Clin. Endocr. Met. 1990. V. 71(4). P. 1051–1055.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Nagataki S. The concept of Hashimoto disease. In: Nagataki S., Mori T., Torizuka K., eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993. P. 539–545.</mixed-citation><mixed-citation xml:lang="en">Nagataki S. The concept of Hashimoto disease. In: Nagataki S., Mori T., Torizuka K., eds. 80 Years of Hashimoto disease. Amsterdam: Elsevier Science, 1993. P. 539–545.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Nevinsky G.A., Buneva V.N. Human catalytic RNA- and DNA-hydrolyzing antibodies // J. Immunol. Methods. 2002. V. 263. P. 235–249.</mixed-citation><mixed-citation xml:lang="en">Nevinsky G.A., Buneva V.N. Human catalytic RNA- and DNA-hydrolyzing antibodies // J. Immunol. Methods. 2002. V. 263. P. 235–249.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ng H.P., Banga J.P., Kung A.W. Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase // Endocrinol. 2004. V. 145(2). P. 809–816.</mixed-citation><mixed-citation xml:lang="en">Ng H.P., Banga J.P., Kung A.W. Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase // Endocrinol. 2004. V. 145(2). P. 809–816.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">O'Leary P.C., Fedolema P.H., Michelangeli V.P. at al. Investigations of thyroid hormones antibodies based on a community health survey: the Busselton thyroid study // Clin. Endocr. 2006. V. 64(1). P. 97–104.</mixed-citation><mixed-citation xml:lang="en">O'Leary P.C., Fedolema P.H., Michelangeli V.P. at al. Investigations of thyroid hormones antibodies based on a community health survey: the Busselton thyroid study // Clin. Endocr. 2006. V. 64(1). P. 97–104.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ota H., Amino N., Morita S. at al. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease // Clin. Endocr. 2007. V. 67(1). P. 41–45.</mixed-citation><mixed-citation xml:lang="en">Ota H., Amino N., Morita S. at al. Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves' disease // Clin. Endocr. 2007. V. 67(1). P. 41–45.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Outschoorn I.M., Hoffman W.H., Rose N.R. et al. Heritability of levels of autoantibodies to thyroid antigens using the method of plotting regression of offspring on midparent (ROMP) // Autoimmunity. 2007. V. 40(5). P. 366–371.</mixed-citation><mixed-citation xml:lang="en">Outschoorn I.M., Hoffman W.H., Rose N.R. et al. Heritability of levels of autoantibodies to thyroid antigens using the method of plotting regression of offspring on midparent (ROMP) // Autoimmunity. 2007. V. 40(5). P. 366–371.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Paul S., Nishiyama Y., Planque S., Taguchi H. Theory of proteolytic antibody occurrence // Immunol. Lett. 2006. 103(1). Р. 8–16.</mixed-citation><mixed-citation xml:lang="en">Paul S., Nishiyama Y., Planque S., Taguchi H. Theory of proteolytic antibody occurrence // Immunol. Lett. 2006. 103(1). Р. 8–16.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Rebuffat S.A., Nguyen B., Robert B. et al. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease // J. Clin. Endocr. Met. 2008. V. 93(3). P. 929–934.</mixed-citation><mixed-citation xml:lang="en">Rebuffat S.A., Nguyen B., Robert B. et al. Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease // J. Clin. Endocr. Met. 2008. V. 93(3). P. 929–934.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Rodien P., Madec A.M., Ruf J. et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies// J. Clin. Endocr. Met. 1996. V. 81(7). P. 2595–2600.</mixed-citation><mixed-citation xml:lang="en">Rodien P., Madec A.M., Ruf J. et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies// J. Clin. Endocr. Met. 1996. V. 81(7). P. 2595–2600.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Rose N.R., Burek C.L. Autoantibodies to thyroglobulin in health and disease // Appl. Biochem. Biotechnol. 2000. V. 83 (Suppl. 1–3). P. 245–251.</mixed-citation><mixed-citation xml:lang="en">Rose N.R., Burek C.L. Autoantibodies to thyroglobulin in health and disease // Appl. Biochem. Biotechnol. 2000. V. 83 (Suppl. 1–3). P. 245–251.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Santoh T., Watanabe M., Kuroda S. et al. Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease // Endocr. J. 2007. V. 54(6). P. 887–894.</mixed-citation><mixed-citation xml:lang="en">Santoh T., Watanabe M., Kuroda S. et al. Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease // Endocr. J. 2007. V. 54(6). P. 887–894.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Takami H.E., Miyabe R., Kameyama K. Hashimoto's Thyroiditis // Wld J. Surg. 2008. V. 32(5). P. 688–692.</mixed-citation><mixed-citation xml:lang="en">Takami H.E., Miyabe R., Kameyama K. Hashimoto's Thyroiditis // Wld J. Surg. 2008. V. 32(5). P. 688–692.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Trbojevic B., Djurica S. Diagnosis of autoimmune thyroid disease // Srp. Arh. Celok. Lek. 2005. V. 133 (Suppl. 1). P. 25–33.</mixed-citation><mixed-citation xml:lang="en">Trbojevic B., Djurica S. Diagnosis of autoimmune thyroid disease // Srp. Arh. Celok. Lek. 2005. V. 133 (Suppl. 1). P. 25–33.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ugurlu S., Caglar E., Yesim T. et al. Anti-Scl-70 antibodies in autoimmune hypothyroidism // J. Int. Med. Res. 2008. V. 36(1). P. 152–156.</mixed-citation><mixed-citation xml:lang="en">Ugurlu S., Caglar E., Yesim T. et al. Anti-Scl-70 antibodies in autoimmune hypothyroidism // J. Int. Med. Res. 2008. V. 36(1). P. 152–156.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Watanabe M., Yamamoto N., Maruoka H. et al. Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease // Thyroid. 2002. V. 12(9). P. 801–808.</mixed-citation><mixed-citation xml:lang="en">Watanabe M., Yamamoto N., Maruoka H. et al. Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease // Thyroid. 2002. V. 12(9). P. 801–808.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Wen W., Liu F. Autoantibodies Highly Increased in Patients with Thyroid Dysfunction // Cell. Molec. Immunol. 2007. V. 4 (3). P. 233–236.</mixed-citation><mixed-citation xml:lang="en">Wen W., Liu F. Autoantibodies Highly Increased in Patients with Thyroid Dysfunction // Cell. Molec. Immunol. 2007. V. 4 (3). P. 233–236.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
